Rezension:
Accountant supermarket manager isotretinoin accutane buy Dr. Eric Rubin, head of oncology clinical development at Merck & Co Inc., said the FDA\'s willingness to allow accelerated approval based upon single-arm studies - without the traditional control group - is \"a big step forward, but it\'s not universally agreed upon,\" especially in Europe.